LCTX: Lineage Cell Therapeutics Inc insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-07-29 | New 13G stake | BlackRock, Inc. | 5.30% | SEC |
Institutional ownership (Q2 2026)
131 institutions reported holding $152.39M of Lineage Cell Therapeutics Inc on Form 13F (130 the quarter before). 33 opened a new position and 32 sold out. Shares held by institutions: +4%.
| Largest holders | Shares | Value |
|---|---|---|
| BROADWOOD CAPITAL INC | 49,560,992 | $64.92M |
| BlackRock, Inc. | 13,186,895 | $17.27M |
| VANGUARD CAPITAL MANAGEMENT LLC | 9,054,918 | $11.86M |
| Defender Capital, LLC. | 6,598,899 | $8.64M |
| GEODE CAPITAL MANAGEMENT, LLC | 5,299,457 | $6.94M |
| RAFFLES ASSOCIATES LP | 5,197,788 | $6.81M |
| FIFTH THIRD BANCORP | 4,600,000 | $6.03M |
| MILLENNIUM MANAGEMENT LLC | 3,018,567 | $3.95M |
| STATE STREET CORP | 2,314,180 | $3.03M |
| VANGUARD FIDUCIARY TRUST CO | 1,668,629 | $2.19M |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.